Skip to main content
European Commission logo print header

Deciphering the molecular language orchestrating host-microbiome interactions and their effects on health and disease

Obiettivo

The gastrointestinal tract hosts the microbiome, one of the highest microbial densities on earth. Diverse host-microbiome interactions influence a multitude of physiological and pathological processes, yet the basic mechanisms regulating host-microbiome interactions remain unknown. Deciphering the codes comprising the host-microbiome communication network and factors initiating loss of homeostasis (termed dysbiosis) will enable the recognition of pathways and signals critically important to initiation and progression of common immune and metabolic disorders. We recently identified the NLRP6 inflammasome as a critical innate immune regulator of colonic microbial ecology, with its disruption resulting in auto-inflammation and tumorigenesis. We will use this unique system, coupled with innovative robotic high-throughput modalities, gnotobiotics, metagenomics and multiple genetically altered mouse models to generalize our studies and decipher the critical principles governing host-microbiome interactions. We will elucidate the host-derived microbiome recognition signaling pathway at its entirety, from its upstream activators to the downstream effector molecules controlling microbial ecology; uncover the principles generating a stable microbiota composition; and develop and apply computational modelling to dissect the general mechanisms disrupting microbiome stability leading to dysbiosis. Using this innovative experimental and computational toolbox we will study the impact of dysbiosis on key components of the metabolic syndrome, and apply our findings to devise the first rational proof-of-concept approach for individualized microbiome-based treatment for these common disorders. At the basic science level, unraveling the principles of host-microbiota interactions will lead to a conceptual leap forward in our understanding of physiology and disease. Concomitantly, it may generate a platform for microbiome-based personalized therapy against common idiopathic illnesses.

Invito a presentare proposte

ERC-2013-CoG
Vedi altri progetti per questo bando

Meccanismo di finanziamento

ERC-CG - ERC Consolidator Grants

Istituzione ospitante

WEIZMANN INSTITUTE OF SCIENCE
Contributo UE
€ 2 000 000,00
Indirizzo
HERZL STREET 234
7610001 Rehovot
Israele

Mostra sulla mappa

Tipo di attività
Higher or Secondary Education Establishments
Ricercatore principale
Eran Elinav (Dr.)
Contatto amministrativo
Gabi Bernstein (Ms.)
Collegamenti
Costo totale
Nessun dato

Beneficiari (1)